" class="no-js "lang="en-US"> SomaLogic Announces Appointment of Shaun Blakeman as Chief Financial Officer - Pharmtech Focus
Wednesday, February 01, 2023

SomaLogic Announces Appointment of Shaun Blakeman as Chief Financial Officer

CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, a leader in AI-data driven proteomics technology, today announced the appointment of Shaun Blakeman as the company’s Chief Financial Officer.

“We are thrilled to welcome Shaun Blakeman to the SomaLogic team,” said SomaLogic Chief Executive Officer Roy Smythe, M.D. “His depth of experience as a financial executive across a range of medical technology companies materially strengthens our leadership team and will make an immediate impact as we continue to rapidly scale our business.”

Mr. Blakeman is a financial executive with over 20 years of professional experience spanning operations, logistics, project management, and accounting and financial leadership. Most recently, he served as Senior Vice President and Chief Financial Officer of Cantel Medical, a public company focused on global infection prevention and control in the endoscopy, hemodialysis water and dental spaces.

Mr. Blakeman has also served as a Senior Finance Director at Medtronic, a leader in medical technology, where he oversaw finance for multiple manufacturing sites in Medtronic’s Restorative Therapies Group. Before that, he was the Vice President of Finance for Cantel, where he was the segment CFO for the company’s $500 million endoscopy platform. Prior to his time at Cantel, Mr. Blakeman spent five years with IDEX in financial leadership positions of increasing responsibility, up to the Vice President of Finance for the company’s diaphragm and dosing pump and water platforms. Prior to IDEX, Mr. Blakeman worked for Eaton in various finance positions. He began his career as an officer in the United States Navy in both Surface Warfare and Engineering Duty specialties.

Mr. Blakeman received his Bachelor of Science in economics from the University of Minnesota, his Master of Science in applied physics from the Naval Postgraduate School, and his Master of Business Administration from the Indiana University Kelley School of Business.

“SomaLogic is a pioneer in furthering the development of proteomics for biomarker discovery and clinical insights,” said Mr. Blakeman. “I am honored to join the organization on its path to improving global healthcare outcomes for patients worldwide.”

People In This Post

Companies In This Post

  1. MedRhythms Feasibility Study Shows Positive Topline Results in Parkinson’s Disease Read more
  2. Ionis receives FDA Fast Track designation for Olezarsen in patients with Familial Chylomicronemia Syndrome Read more
  3. Sensorion and EVEON Collaborating to Develop an Injection System for the Delivery of Gene Therapy Treatments Into the Inner Ear Read more
  4. Qurient Announces Dosing of First Patient in Clinical Study for the Treatment of Patients with Solid Tumors Read more
  5. Marinus Pharmaceuticals Appoints Christine Silverstein to its Board of Directors Read more